Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
Official title: A bill to amend the Animal Health Protection Act to reauthorize animal disease prevention and management programs.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry.
Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023
This bill provides additional funding for Animal and Plant Health Inspection Service (APHIS) animal disease prevention and management programs and reauthorizes the programs through FY2028.
Specifically, the bill reauthorizes and provides additional funding for
- the National Animal Health Laboratory Network (a nationally coordinated network and partnership of federal, state, and university-associated animal health laboratories that provides animal health diagnostic testing to detect biological threats to the nation's food animals);
- the National Animal Disease Preparedness and Response Program (which allows APHIS to partner with states, tribes, producer organizations, universities, and others to carry out projects that enhance local, regional, and national capabilities to prevent, prepare for, and respond to animal disease outbreaks); and
- the National Animal Vaccine and Veterinary Countermeasures Bank (which allows the Department of Agriculture to stockpile animal vaccines and related products to use in the event of an outbreak of foot-and-mouth disease or other high-impact foreign animal diseases).
- Introduced in Senate Formatted Text PDF Formatted XML
- BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
- BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
- BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
- BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Bodies those filers lobbied
Cite this page
U.S. Congress. (2026). S. 1666: Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-S-1666/
"S. 1666: Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-1666/.
S. 1666, 118th Cong. (2026), https://openamerica.io/bill/118-S-1666/.
[S. 1666: Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act of 2023](https://openamerica.io/bill/118-S-1666/)